Tofacitinib (Compound)

Synonyms:Tofacitinib, Tasocitinib, 477600-75-2, 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile, CP-690550, CP 690550, 1259404-17-5, rac-Tofacitinib, CP-690,550, Tofacitinib (CP-690550,Tasocitinib), 3-((3R,4R)-rel-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile, Tofacitinib [USAN], Cp-690 free base, CP690550, CHEMBL221959, 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile, C16H20N6O, CHEBI:71200, racemic-Tasocitinib, 87LA6FU830, CP-690550 FREE BASE, CP-690,550 FREE BASE, 477600-75-2 (free base), Tofacitinib (USAN), CP690,550, CP-690-550, 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile, 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile, MFCD11035919, 3-[(3R*,4R*)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile, 3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile, 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo(2,3-d)pyrimidin-4-yl-, (3R,4R)-, Tofacitinib [USAN:INN], tofacitinibum, UNII-87LA6FU830, 3eyg, 3fup, 3lxk, 4oti, 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile, MI1, TOFACITINIB [MI], (+)-TOFACITINIB, TOFACITINIB [INN], TOFACITINIB [VANDF], TOFACITINIB [WHO-DD], SCHEMBL322753, Tofacitinib (CP-690550), GTPL5677, HSDB 8311, AMY3992, DTXSID90197271, EX-A205, BCPP000274, BDBM50193995, NSC782351, NSC800953, s2789, AKOS005145814, AKOS005258733, AC-8193, BCP9000550, CCG-264998, CS-0050, DB08895, GS-6106, NSC-782351, NSC-800953, NCGC00229511-02, NCGC00229511-04, NCGC00229511-10, NCGC00244463-01, Tofacitinib (CP-690550, Tasocitinib), HY-40354, A7301, CP- 690 550, D09970, AB01565786_02, EN300-1718468, AR-270/43507983, J-524314, Q3530324, BRD-K31283835-001-01-9, BRD-K31283835-048-04-4, 3-((3R,4R)-4-Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yi)Amino)Piperidin-1-Yl-3-Oxopropaneni, (3R,4R)-3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile, (3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidine propanenitrile, 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-, 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidyl]-3-oxo-propanenitrile, 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]piperidin-1-yl}-3-oxo-propionitrile, 3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile, 3-{4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile, Tofacitinib;3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile

Id:9926791

Description:nan